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Cardiologico, Florianopolis, Santa Catarina, Brazil.BACKGROUND Limited data exist on procedural and biophysical
indicators of pulmonary vein (PV) isolation durability after the
cryoballoon ablation of atrial ﬁbrillation (AF).
OBJECTIVE The aim of this study was to investigate the procedural
and biophysical characteristics associated with late PV reconnec-
tion (PVR) and durable PV isolation (PVI) after cryoablation using
the currently available second-generation cryoballoon.
METHODS Data from 435 PVs targeted in 112 consecutive patients
who underwent a repeat procedure 14  3 months after an index
cryoablation of AF were examined.
RESULTS Altogether, 111 PVs (25.5%) in 71 patients (63.4%)
demonstrated PVR, whereas 324 PVs (74.5%) exhibited PVI. The
number and duration of cryoballoon applications did not differ
between PVR and PVI. However, the time to PV isolation (time to
effect) was considerably shorter (39.1  11.7 seconds vs 67.6 
19.7 seconds; Po .001), the balloon temperature at time to effect
was signiﬁcantly warmer (32.11C  7.81C vs 39.41C  5.81C;
P o .001), the balloon nadir temperature was slightly cooler
(48.71C  4.61C vs 47.81C  2.91C; P ¼ .034), and the total
thaw time (56.5 25.4 seconds vs 34.8 9.1 seconds; Po .001)
and interval thaw times at 01C (iTT0; 14.8 10.9 seconds vs 7.1
2.0 seconds; Po .001) and 151C (54.2  25.4 seconds vs 33.3 Dr Aryana, Dr de Asmundis, Dr O’Neill, Dr Brugada, and Dr Chierchia
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However, only a time to effect ofr60 seconds and an iTT0 ofZ10
seconds emerged as signiﬁcant predictors of PV isolation durability.
Consequently, in a multivariate model, presence of both criteria
predicted o1% and their mere absence 75% likelihood of PVR.
CONCLUSION A time to effect ofr60 seconds and an iTT0 ofZ10
seconds signiﬁcantly predict PV isolation durability after the
cryoballoon ablation of AF. If both criteria are met, the likelihood
of PV reconnection may be exceedingly low.
KEYWORDS Ablation; Atrial ﬁbrillation; Cryoballoon; Pulmonary
vein isolation; Reconnection
ABBREVIATIONS AF ¼ atrial ﬁbrillation; AUC ¼ area under the
curve; CBA ¼ cryoballoon application; CBAd ¼ cryoballoon
application duration; FreezeAUC ¼ freeze area under the curve;
iTT0 ¼ interval thaw time at 01C; iTT15 ¼ interval thaw time at
151C; PV ¼ pulmonary vein; PVI ¼ durable pulmonary vein
isolation; PVR ¼ late pulmonary vein reconnection; ROC ¼
receiver operating characteristic; TempCryoballoon ¼ cryoballoon
temperature; tTT ¼ total thaw time
(Heart Rhythm 2016;13:424–432) I 2016 Heart Rhythm Society.
Open access under CC BY-NC-ND license.Introduction
Limited data exist on procedural and biophysical predictors
of pulmonary vein (PV) isolation durability after the
cryoballoon ablation of atrial ﬁbrillation (AF). Although
optimal PV occlusion using the cryoballoon remains an
important determinant of PV isolation,1,2 its quantiﬁcation
may be difﬁcult and subjective. Consequently, several
quantiﬁable measures of cryolesion quality have been
investigated, including biophysical metrics such as thehttp://dx.doi.org/10.1016/j.hrthm.2015.10.033
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(TempCryoballoon),
2,3 and balloon thaw time,2 as well proce-
dural variables including the number of cryoballoon appli-
cations (CBAs)4 and time to PV isolation measured in real
time (also known as the time to effect).5–9 Yet, there remains
a paucity of comparative data on the signiﬁcance and
predictability of various procedural and biophysical varia-
bles in relation to the durability of PV isolation after
cryoballoon ablation, particularly using the currently avail-
able second-generation cryoballoon (Arctic Front Advance,
Medtronic, Inc, Minneapolis, MN). The aim of this study
was to investigate the association between procedural and
biophysical variables and durability of PV isolation after
cryoablation using the second-generation cryoballoon.
Methods
Study patients
The study cohort consisted of consecutive patients under-
going a repeat procedure for recurrent atrial arrhythmias after
a ﬁrst-time cryoballoon ablation for the treatment of symp-
tomatic AF refractory to Z1 antiarrhythmic agent, which
was performed at Mercy General Hospital, Sacramento, CA,
and Vrije Universiteit Brussel, Brussels, Belgium. The
inclusion criterion consisted of availability of procedural
and biophysical data from the index ablation procedure,
including time to effect measurements recorded in Z3 PVs
per patient. Approval for this study was granted by each
facility’s institutional review board.
Index procedural details
Diagnostic electrophysiology catheters were positioned fol-
lowed by single transseptal catheterization. Intravenous
heparin was administered at the time of transseptal puncture
followed by an infusion (activated clotting time target of
Z300 seconds). All patients underwent PV isolation using a
23-/28-mm cryoballoon (Arctic Front Advance) inserted
through a 15-F steerable sheath (FlexCath, Medtronic, Inc)
over a 20-mm circular inner lumen mapping catheter
(Achieve, Medtronic, Inc). Balloon size selection was guided
by PV size/anatomy as determined by preprocedural com-
puted tomographic or intraprocedural left atrial angiography.
Optimal cryoballoon positioning was conﬁrmed by PV
angiography. Between 1 and 3 CBAs (2–4 minutes) were
delivered to each PV. PV isolation was conﬁrmed by
entrance/exit block and after the administration of intra-
venous adenosine.
Luminal esophageal temperature was monitored through-
out ablation. Esophageal temperatureso151Cwere avoided.
During cryoablation of the right PVs, high-output right
phrenic nerve stimulation (20–25 mA, 1000–1200 ms) was
performed using a diagnostic catheter placed in the superior
vena cava. Whenever diminished/loss of pacing capture was
observed, cryoablation was immediately terminated. Phrenic
nerve palsy was classiﬁed as either transient or persistent.
Transient phrenic nerve palsy was deﬁned as diminished/
absence of pacing capture during phrenic nerve stimulationat the time of ablation with eventual resolution before the end
of procedure, whereas persistent phrenic nerve palsy was
characterized by continued loss of phrenic nerve function
that persisted during follow-up.
Postprocedural management
Patients were discharged from the hospital within 1 day of
the procedure. Oral anticoagulation was resumed on the
evening after the procedure and continued for a minimum of
3–6 months. Antiarrhythmic therapy was discontinued
within 3 months of ablation. In addition to routine electro-
cardiograms obtained during each follow-up visit, 2- to 4-
week ambulatory electrocardiographic monitoring was also
performed at 6 weeks, 3 months, 6 months, and 13 months.
In patients with persistent or unexplained pulmonary symp-
toms (eg, persistent cough or dyspnea), repeat cardiac
computed tomographic angiography was performed. Patients
with persistent phrenic nerve palsy underwent outpatient
serial radiography for reassessment during follow-up.
Repeat procedure and classiﬁcation of CBAs
Presence or absence of PV isolation was evaluated and
documented for each PV at the redo procedure in all the
patients included in this analysis. If PV reconnection had
occurred, the reconnected PV was reisolated using radio-
frequency or cryoballoon ablation on the basis of operator
discretion using conventional methods. Meanwhile, using
these data, the CBAs delivered during index procedures were
classiﬁed as associated with either (1) durable PV isolation
(PVI) or (2) late PV reconnection (PVR).
Demographic, procedural, and biophysical data
Patient demographic data were obtained from reviewing the
medical records. Procedural characteristics including (1)
number of delivered CBAs, (2) CBA duration (CBAd) (in
minutes), and (3) time to effect (in seconds) were collected.
Time to effect was deﬁned as the precise duration required to
achieve PV isolation during a given CBA. A standardized
approach, as described previously,7 was adopted for deter-
mining the time to effect by all operators. Brieﬂy, this
approach involved (1) “real-time” recording of PV electro-
gram at a proximal site within the ostium of each PV before
ablation using the Achieve circular mapping catheter inserted
via the inner lumen of the cryoballoon and (2) manual
recording of the time duration required to achieve PV
isolation determined by complete disappearance of the PV
electrogram and/or its dissociation from left atrial activity
during the CBA.
In addition, the cryoablation binary data ﬁles stored in the
CryoConsole were used to analyze various biophysical
measurements, including balloon cooling rate and interval
and total thaw times. Cooling rate was classiﬁed as
TempCryoballoon (1C) reached at (1) 30 seconds and (2) 60
seconds. In addition, TempCryoballoon (1C) at time to effect
and TempCryoballoon (1C) at nadir were recorded. The latter
was deﬁned as the lowest temperature attained during a given
Table 1 Baseline patient demographic characteristics (N ¼ 112)
Characteristic Value
Age (y) 64  12
Sex: male 80 (71)
Hypertension 72 (64)
Diabetes mellitus 16 (14)
Chronic obstructive pulmonary disease 14 (13%)
Obstructive sleep apnea 13 (12)
Heart failure 15 (13)
Left ventricular ejection fraction (%) 57  10
Left atrial diameter (mm) 44  6
Coronary artery disease 16 (14)
Paroxysmal AF 85 (76)
Duration of AF (y) 3.8  2.7
Previous cardioversion 79 (71)
No. of cardioversions per patient 1.0  0.9
CHA2DS2-VASc score 2.3  1.7
Antiarrhythmic drugs 81 (72)
No. of failed antiarrhythmic drugs per patient 0.9  0.8
Values are presented as mean  SD or as n (%).
AF ¼ atrial ﬁbrillation.
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also analyzed, which were deﬁned as the time needed for the
balloon to rewarm/thaw upon completion of the CBA. They
were documented for TempCryoballoon reaching (1) 01C
(iTT0), (2) 151C (iTT15), and (3) 201C. The last corresponds
to total thaw time (tTT). An interval thaw time at 151C was
selected since this is generally the TempCryoballoon limit at
which the balloon is manually stretched by the operator upon
termination of CBA.2 For each CBA, we also determined the
freeze area under the curve (FreezeAUC) and FreezeAUC/
CBAd. As described previously,
10 the area under the freezing
curve is a comprehensive metric used to assess the magni-
tude of cryoablation. It is an approximation of the integral of
temperature across time using the trapezoidal method that
encompasses cooling rate, nadir TempCryoballoon, and thaw
time (speciﬁcally iTT0). It was calculated for every CBA by
determining the surface area below 01C (Figure 1). This area
extends from the point at which TempCryoballoon falls below
01C through the time point at which the balloon rewarms to
01C. In order to standardize this entity per unit time, the
overall value was divided by CBAd to yield FreezeAUC/
CBAd for each CBA. Also, in a subset of patients, the degree
of PV occlusion was examined by contrast medium injection
through the lumen of the cryoballoon into the PV at the time
of ablation. The degree of PV occlusion was adjudicated
using a semiquantitative scale (grades 1–4), as described
previously.11 Lastly, since the PVs were typically ablated
using41 CBA, the most extreme values achieved by a given
biophysical variable were used in this analysis.Figure 1 Determination of FreezeAUC. FreezeAUC is a comprehensive
measure used to assess the magnitude of cryoablation. It is calculated by
determining the surface area below 01C within the shaded zone, extending
from the point at which TempCryoballoon falls below 01C (FreezeStart) through
the time point at which the balloon rewarms to 01C (FreezeEnd). This entity
collectively reﬂects several biophysical parameters including cooling rate
(A), nadir TempCryoballoon (B), and iTT0 (C). This ﬁgure also depicts iTT15
and tTT. As seen here, the last 2 variables are not included in the
computation of FreezeAUC. FreezeAUC ¼ freeze area under the curve;
iTT0 ¼ interval thaw time at 01C; iTT15 ¼ interval thaw time at 151C;
TempCryoballoon ¼ cryoballoon temperature; tTT ¼ total thaw time.Statistical methods
Continuous variables were analyzed using a 2-sample t test
and Mann-Whitney U test for parametric and nonparametric
analysis, respectively. Categorical variables were analyzed
using the χ2 or Fisher exact test. Cohran’s Q test for the
proportion of matched pairs was used to compare the
frequency of PV reconnection in multiple groups and the
McNemar test to compare the same frequency between
individual PVs. Ascertaining predictors of PVI were identi-
ﬁed by multivariate logistic regression modeling using
statistically signiﬁcant variables. Stepwise regression was
performed, eliminating all variables with P 4 .10. This
resulted in a parsimonious model providing an odds ratio and
95% conﬁdence intervals for the primary outcome. Receiver
operating characteristic (ROC) curves corresponding to the
selected logistic regression models were constructed, and the
area under the curve (AUC) was calculated to provide a
summary measure of the accuracy of the prediction model.
Lastly, correlation coefﬁcients were generated using the
Spearman test, correlating PV occlusion with various proce-
dural and biophysical variables. For all analyses, P values
were 2-sided and a P value of o.05 was considered
signiﬁcant. The analyses were conducted with Stata 13
(StataCorp LP, College Station, TX).Results
Altogether, data from 435 PVs in 112 consecutive patients
who underwent a repeat procedure because of recurrent atrial
arrhythmias, 14  3 months after an index cryoballoon
ablation of AF, were analyzed. Baseline patient demographic
characteristics are presented in Table 1, and the procedural
and clinical outcomes are presented in Table 2. Complete
electrical isolation was achieved in 100% of the PVs at the
index procedure. Brieﬂy, in 71 patients (63.4%), 111 PVs
(25.5%) showed evidence of late reconnection and 165 PVs
Table 2 Procedural and clinical outcomes (n ¼ 112)
Outcome Value
Cryoballoon used
28 mm 110 (98)
23 mm 3 (3)
Time
PV isolation (min) 29  2
Fluoroscopy (min) 22  10
Procedure (min) 99  20
Reconnected PVs
Left common 6 (60.0)
Left superior 18 (17.6)
Left inferior 19 (18.6)
Right superior 26 (23.2)
Right inferior 42 (37.5)
Adverse events
Transient phrenic nerve palsy 7 (6.3)
Femoral pseudoaneurysm 1 (0.9)
Gastroparesis 1 (0.9)
Persistent phrenic nerve palsy 2 (1.8)
Atrial ﬂutter/tachycardia 8 (7.1)
Values are presented as mean  SD or as n (%).
PV ¼ pulmonary vein.
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(36.6%) with 159 PVs (36.5%) exhibited permanent iso-
lation of all PVs at the redo procedure. The frequency of
right inferior PV reconnection signiﬁcantly differed from the
other PVs (P o .001). Extension of comparisons between
individual groups revealed that the right inferior PV exhib-
ited a higher incidence of reconnection as compared with the
left superior PV (Po .001), left inferior PV (P ¼ .001), and
right superior PV (P ¼ .011), but a lower frequency than the
left common PV (P ¼ .031). Detailed comparisons of
procedural and biophysical variables comparing PVR and
PVI are depicted in Table 3. While the total number and
duration of CBAs/PV did not differ between the groups, the
time to effect was signiﬁcantly shorter for PVI. Also,Table 3 Comparisons of procedural and biophysical parameters betwee
Variable PVR (n ¼ 111)
Procedural
No. of CBAs/PV 2.2  0.6
CBAd/PV (min) 3.4  0.2
Time to effect (s) 68  20
Biophysical
TempCryoballoon at 30 s (1C) 27  8
TempCryoballoon at 60 s (1C) 40  7
TempCryoballoon at time to effect (1C) 39  6
Nadir TempCryoballoon (1C) 48  3
iTT0 (s) 7  2
iTT15 (s) 33  9
tTT (s) 35  9
FreezeAUC (1C) 8.2  1.8  1
FreezeAUC/CBAd (1C) 35  8
Values are presented as mean  SD or as n (%).
CBA ¼ cryoballoon application; CBAd ¼ cryoballoon application duration; Fr
iTT15 ¼ interval thaw time at 151C; PV ¼ pulmonary vein; PVI ¼ durable PV isolat
tTT ¼ total thaw time.
*Signiﬁcant P value.TempCryoballoon at the time to effect was signiﬁcantly war-
mer and TempCryoballoon at 30 and 60 seconds and nadir
TempCryoballoon were signiﬁcantly colder for PVI compared
to PVR. In addition, interval and total thaw times were
signiﬁcantly longer and FreezeAUC and FreezeAUC/CBAd
were considerably cooler for PVI than for PVR.
Based on ROC curve analyses (Figure 2), time to effect
(0.9016) and iTT0 (0.8454) yielded the greatest AUC values.
Furthermore, as shown in Table 4, a time to effect of r60
seconds emerged as the best predictor of PVI (Youden
index ¼ 1.66), followed by an iTT0 of Z10 seconds
(Youden index ¼ 1.56), an iTT15 ofZ50 seconds (Youden
index¼ 1.47), a TempCryoballoon at time to effect ofr351C
(Youden index ¼ 1.45), a FreezeAUC of r9  1031C
(Youden index ¼ 1.43), a tTT of Z60 seconds (Youden
index¼ 1.39), and a FreezeAUC/CBAd ofr421C (Youden
index ¼ 1.31). A stepwise logistic multivariate regression
analysis identiﬁed only time to effect and iTT0 as signiﬁcant
predictors of PVI (Table 5). Subsequently, a multivariate
model composed of a time to effect ofr60 seconds and an
iTT0 ofZ10 seconds yielded an ROC curve with an AUC of
0.8941. On the basis of this model, the likelihood of PV
reconnection was determined to be 0.88% if both of these
criteria are met (sensitivity 100.0%; speciﬁcity 0.0%),
18.02% if only 1 criterion is met (sensitivity 95.8%;
speciﬁcity 44.2%), and 74.56% if neither criterion is met
(sensitivity 77.1%; speciﬁcity 95.6%).
Moreover, in a subset of 125 PVs in 32 patients for whom
the data were available, the magnitude of PV occlusion
during CBA highly correlated with a time to effect of r60
seconds and an iTT0 ofZ10 seconds. That is, a time to effect
ofr60 seconds was associated with a grade 2 PV occlusion
in 7 PVs (9.3%), a grade 3 in 18 PVs (24.0%), and a grade 4
in 50 PVs (66.7%) (P o .001). Similarly, an iTT0 of Z10
seconds was associated with a grade 2 PV occlusion in 2 PVs
(4.2%), a grade 3 in 11 PVs (22.9%), and a grade 4 in 35 PVsn the groups
PVI (n ¼ 324) P
2.1  0.3 .751
3.4  0.7 .445
39  12 o.001*
28  16 .015*
41  16 .001*
32  8 o.001*
49  5 .034*
15  11 o.001*
54  25 o.001*
56  25 o.001*
03 10.1  2.2  103 .001*
43  10 o.001*
eezeAUC ¼ freeze area under the curve; iTT0 ¼ interval thaw time at 01C;
ion; PVR ¼ late PV reconnection; TempCryoballoon ¼ cryoballoon temperature;
Figure 2 ROC curves predicting durability of PV isolation. ROC curves include the area-under-the-curve values with regard to permanent PV isolation for
time to effect (A), TempCryoballoon at time to effect (B), nadir TempCryoballoon (C), iTT0 (D), iTT15 (E), tTT (F), FreezeAUC (G), and FreezeAUC/CBAd (H).
CBAd ¼ cryoballoon application duration; FreezeAUC ¼ freeze area under the curve; iTT0 ¼ interval thaw time at 01C; iTT15 ¼ interval thaw time at 151C;
ROC ¼ receiver operating characteristic; TempCryoballoon ¼ cryoballoon temperature; tTT ¼ total thaw time.
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Table 4 Procedural and biophysical variables as predictors of
durability of PV isolation in receiver operating characteristic curve
analyses
Variable Cutoff Sensitivity (%) Speciﬁcity (%)




iTT0 Z10 s 90.9 65.1
iTT15 Z50 s 96.4 50.3
tTT Z60 s 99.1 39.8
FreezeAUC r9  1031C 73.9 69.1
FreezeAUC/CBAd r421C 84.7 46.3
CBAd ¼ cryoballoon application duration; FreezeAUC ¼ freeze area under
the curve; iTT0 ¼ interval thaw time at 01C; iTT15 ¼ interval thaw time at
151C; TempCryoballoon ¼ cryoballoon temperature; tTT ¼ total thaw time.
429Aryana et al Cryoablation Predictors of Durable PVI(72.9%) (Po .001). In addition, presence of both (a time to
effect of r60 seconds and an iTT0 of Z10 seconds) was
associated with a grade 2 PV occlusion in 1 PV (2.9%), a
grade 3 in 5 PVs (14.7%), and a grade 4 in 28 PVs (82.4%)
(P o .001). Table 6 lists correlation coefﬁcients generated
by using the Spearman test correlating the magnitude of PV
occlusion with various procedural and biophysical variables
for the available observations. As shown, aside from PV
reconnection itself, time to effect, iTT0, and tTT most closely
correlated with the magnitude of PV occlusion.
Lastly, a comparison of procedural and biophysical
parameters derived from a cohort of matched patients (n ¼
82) without atrial arrhythmia recurrence during 12 months of
follow-up compared to PVI yielded no discernible differ-
ences in the number and duration of CBAs, the time to effect,
and TempCryoballoon at 30 seconds, 60 seconds, time to effect,
and nadir. Similarly, interval and total thaw times, Freeze
AUC, and FreezeAUC/CBAd did not differ between these 2
groups. However, the ROC curve analyses with respect to
atrial arrhythmia recurrence provided considerably lower
Youden indices and meager AUC values for all the variables:
time to-effect (0.6728), TempCryoballoon at time to effect
(0.5989), nadir TempCryoballoon (0.4991), iTT0 (0.5550),
iTT15 (0.5567), tTT (0.5641), FreezeAUC (0.5690), and
FreezeAUC/CBAd (0.5648).Table 5 Signiﬁcant procedural and biophysical predictors of





error z P 95% CI
Time to
effect
1.13 0.027 5.29 o.001* 1.08–1.19
iTT0 0.62 0.076 3.84 o.001* 0.49–0.79
CI ¼ conﬁdence interval; iTT0 ¼ interval thaw time at 01C; PV ¼
pulmonary vein.
*Signiﬁcant P value.Discussion
To our knowledge, this study represents the ﬁrst compre-
hensive analysis evaluating procedural and biophysical
determinants of effective PV isolation during cryoballoon
ablation of AF using the second-generation cryoballoon. As
such, this analysis provides several important insights. First,
it conﬁrms the notion that neither the duration nor the
number of CBAs are predictive of procedural success and
that longer and greater number of CBAs do not necessarily
enhance the quality of suboptimal cryoballoon ablation.
Second, it evokes time to effect and iTT0 as the dominant
procedural and biophysical indicators of PVI. As such, in a
multivariate model incorporating a time to effect of r60seconds and an iTT0 ofZ10 seconds, the likelihood of PVR
was found to be exceedingly low (o1%) if both benchmarks
are attained, and eminently high (75%) if neither criterion
is met. Moreover, in the subset of patients investigated, the
magnitude of PV occlusion correlated well with the time to
effect and iTT0, further highlighting the signiﬁcance of
optimal PV occlusion during cryoballoon ablation.
While previous studies2,3 investigating the biophysical
variables of cryoablation have exclusively used the ﬁrst-
generation cryoballoon (Arctic Front, Medtronic, Inc), the
results of the present study using the second-generation
cryoballoon seem strikingly similar, suggesting that in
essence the general behavior of the 2 cryoballoons remains
largely unchanged. Cryoablation depends on the essential
balloon-tissue contact to create optimal cryolesions and
achieve PVI. As such, the magnitude of PV occlusion
remains an important benchmark for this procedure.1 How-
ever, since the latter is not easily quantiﬁable nor terribly
objective, several other biophysical2,3 and procedural4–9
characteristics have been investigated in a series of single-
center studies as potential surrogates. Within the biophysical
realm, cryoballoon thaw time, cooling rate, and nadir
TempCryoballoon have been evaluated as possible predictors
of PV reconnection.2,3 A prolonged balloon thaw time is
believed to signify a colder CBA with longer therapeutic ice
crystallization. The latter is a process that occurs during the
thawing phase of the cryoballoon and is believed to promote
additional cellular injury.12 Therefore, longer thawing inter-
vals may not only represent a marker of colder CBAs but
also more effective CBAs.2 Consistent with this, the present
study found that both interval and total balloon thaw times
were highly prognostic of permanent PV isolation. Further-
more, this study speciﬁcally implicates iTT0, or the time
required for nadir TempCryoballoon to reach 01C, as the most
critical biophysical variable. This is conceivable since during
tissue thawing, a longer iTT0 likely indicates cooler temper-
atures at the cryoadhesion site and the tissue itself, as well as
enhanced therapeutic ice crystallization.
The impact of balloon cooling rate was investigated by
Ghosh et al.2 Speciﬁcally, the authors evaluated the “freezing
time” using the ﬁrst-generation cryoballoon, deﬁned as the
time necessary for the balloon to cool from 0 to30ºC. They
found that this parameter was not predictive of PVR.
Furthermore, Fürnkranz et al3 examined nadir TempCryoballoon
Table 6 Magnitude of PV occlusion on angiography and correlation with PV reconnection and procedural and biophysical variables (n¼ 125)
Outcome/variable
Grade of PV occlusion
Spearman ρ P2 (n ¼ 20) 3 (n ¼ 45) 4 (n ¼ 60)
PV reconnection 14 (70) 21 (47) 7 (12) 0.5754 o.001*
Procedural variable
CBAd/PV (min) 3.4  0.4 3.5  0.8 3.5  0.8 0.0540 .549
Time to effect (s) 63  24 55  17 38  12 0.5912 o.001*
Biophysical variable
TempCryoballoon at 30 s (1C) 28  9 24  18 30  14 0.2059 .059
TempCryoballoon at 60 s (1C) 40  6 39  15 44  14 0.2834 .055
TempCryoballoon at time to effect (1C) 38  6 34  9 32  8 0.3313 .031*
Nadir TempCryoballoon (1C) 47  3 48  5 50  6 0.1806 .044*
iTT0 (s) 7  2 10  7 15  12 0.5980 o.001*
iTT15 (s) 27  7 40  18 61  26 0.4068 o.001*
tTT (s) 28  6 42  18 63  26 0.5855 o.001*
FreezeAUC (1C) 8.4  1.8  103 9.3  2.3  103 10.3  2.9  103 0.2309 .003*
FreezeAUC/CBAd (1C) 36  9 40  14 43  11 0.2678 .001*
CBAd¼ cryoballoon application duration; FreezeAUC¼ freeze area under the curve; iTT0¼ interval thaw time at 01C; iTT15¼ interval thaw time at 151C; PV¼
pulmonary vein; TempCryoballoon ¼ cryoballoon temperature; tTT ¼ total thaw time.
*Signiﬁcant P value.
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invariably associated with acute PV isolation. However, no
long-term data were provided with regard to durability of PV
isolation. Indeed, in the present study we discovered similar
outcomes. That is, our study identiﬁed balloon cooling rate as
a nonpredictor and nadir TempCryoballoon as a weak, albeit
signiﬁcant predictor of PV isolation durability. Similarly, as
seen in Table 6, nadir TempCryoballoon exhibited only a slight
correlation and balloon cooling rate exhibited lack of a
correlation with the magnitude of PV occlusion on angiog-
raphy. These observations are not unexpected, since absolute
TempCryoballoon is likely pervious to several confounding
variables. To appreciate this, it is important to ﬁrst examine
the location of the thermocouple on the cryoballoon. The
latter is located on the proximal segment of the balloon
catheter, generally farthest from the site of cryoadhesion. As
such, the recorded TempCryoballoon is not a precise measure of
the temperature within the ablated tissue. Instead, it is
inﬂuenced not only by the degree of PV occlusion but also
by the size of the cryoballoon used (23 mm vs 28 mm, with
the latter exhibiting 50% greater surface area), the balloon
position within the PV ostium (proximal vs distal), the
balloon-to-PV size ratio, as well as the ipsilateral PV blood
ﬂow. Therefore, it is unlikely that absolute TempCryoballoon
during ablation would by itself emerge as a powerful
predictor of procedural outcomes. In addition, we observed
that the ROC curve for nadir TempCryoballoon was bimodal.
That is, it crossed the line of unity, suggesting that down to a
certain threshold (561C), a colder nadir TempCryoballoon was
indeed associated with reduced incidence of PV reconnec-
tion. However, a nadir TempCryoballoon of r571C was
contrariwise associated with a higher PV reconnection rate.
This is plausible since ultracold TempCryoballoon could in fact
result from more distal cryoballoon placements within the PV
ostia, thereby precluding wide area circumferential PV
ablation. The other biophysical parameters that weresigniﬁcantly associated with PVI included FreezeAUC and
FreezeAUC/CBAd. It should be pointed out that both these
comprehensive variables encompass not only iTT0 but also
the balloon cooling rate and nadir TempCryoballoon. This may
explain why FreezeAUC and FreezeAUC/CBAd behaved as
weaker indicators of permanent PV isolation when compared
with iTT0.
Meanwhile, this study speciﬁcally underscores the impor-
tance of time to effect, which distinctly emerged as the most
powerful predictor of PVI—in effect, rendering it the most
formidable prognostic indicator of procedural success.
Although, to our knowledge, no other study has systemati-
cally evaluated the prognostic value of time to effect in
comparison to various procedural and biophysical metrics,
the role and signiﬁcance of time to effect has in fact been
depicted in several preceding studies.5–9 In a previous report,
Chierchia et al6 showed that early PV reconnection was
associated with a signiﬁcantly longer time to effect (117 
25 seconds vs 59 25 seconds; Po .005). Similarly, Chun
et al8 demonstrated that time to effect was signiﬁcantly
shorter in conjunction with PVI (66  56 seconds vs 129 
76 seconds; Po .001). Kühne et al9 further conﬁrmed these
ﬁndings by reporting a mean time to effect of 61 seconds in
PVs versus 184 seconds in those without durable isolation.
Although clearly valuable, the latter is not always discern-
ible, since it cannot be reliably assessed during cryoablation
across all PVs in all patients.6–9 This is in part due to the
relatively small diameter of the Achieve mapping catheter
and in part related to the design of the currently available
cryoballoon. That is, the prolonged tip of the Arctic Front
Advance balloon can frequently impede sufﬁcient with-
drawal of the Achieve catheter to a more proximal position
within the PV ostia where the muscular sleeves typically lie.
Perhaps, the availability of the next generation cryoballoon
(Arctic Front Advance ST) that exhibits a signiﬁcantly
shorter distal tip will partly overcome this limitation.
431Aryana et al Cryoablation Predictors of Durable PVIThus, for now, the prognostic utility of other biophysical
parameters still remain pertinent and of great value, partic-
ularly during cases in which the time to effect cannot be
measured consistently.
Finally, in the present study, the procedural and biophys-
ical variables that signiﬁcantly predicted permanent PV
isolation failed to emerge as strong predictors of long-term
freedom from atrial arrhythmias. Although AF recurrence
after catheter ablation is commonly associated with PV
reconnection13 and it is plausible that measures that improve
durability of PV isolation should consequently enhance the
clinical efﬁcacy associated with this procedure; the mecha-
nisms responsible for arrhythmia recurrence after AF ablation
remain multifaceted and complex. Furthermore, absence of
recurrent documented AF/atrial arrhythmias after ablation
does not necessarily corroborate presence of PVI. Thus, it is
not surprising that the procedural and biophysical parameters
investigated in this study failed to emerge as strong indicators
of arrhythmia recurrence during long-term follow-up.
In summary, the main ﬁndings of this analysis suggest that
of the studied procedural and biophysical variables, a time to
effect ofr60 seconds and an iTT0 ofZ10 seconds serve as
the best predictors of PV isolation durability in long-term
follow-up. Hence, routine assessment of these parameters to
guide cryoballoon ablation of AF is strongly encouraged.Study limitations
First, this study represents a retrospective analysis examining
an association between several procedural and biophysical
variables and PV reconnection at the repeat procedure. As
such, it does not provide prospective validation with respect
to any of the study ﬁndings. Second, the analyzed data were
derived exclusively from patients with arrhythmia recurrence
in whom time to effect could be measured in Z3 PVs.
Hence, it represents a selected patient population as opposed
to consecutive patients undergoing cryoballoon ablation.
Third, the data derived from the variables were not obtained
from a single application, as the PVs were typically ablated
using 41 CBA. Although we speciﬁcally attempted to
control for this by selecting the most extreme values
achieved by a given variable in order to reﬂect its maximal
effect, it is conceivable that inter-CBA variability could have
created a source of confound within this study. Fourth, in this
study the biophysical data were derived largely from
anatomically normal PVs. That is, extreme PV sizes such
as left common or exceptionally small PVs were overall
underrepresented. Therefore, our ﬁndings may not be
necessarily extrapolated to atypical PV sizes/morphologies.
Fifth, the analysis performed on PV occlusion included only
a subset of patients and not the entire cohort. Lastly, it is
conceivable that PV reconnection may have occurred in
some patients without arrhythmia recurrence. However,
these patients would have not been captured in this analysis.
In addition, this study included only patients with documentedarrhythmia recurrence. Thus, asymptomatic atrial arrhythmias
could have gone undetected.
Conclusion
A time to effect of r60 seconds and an iTT0 of Z10
seconds signify the best indicators of permanent PV isolation
during cryoballoon ablation of AF. In a multivariate model,
presence of both criteria predicted o1% and their mere
absence 75% likelihood of PVR. In contrast, the number
and duration of CBAs failed to predict PV isolation
durability. Collectively, these ﬁndings highlight the impor-
tance of the “quality” as opposed to the “quantity” of
cryoballoon ablation of AF.
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Heart Rhythm, Vol 13, No 2, February 2016432CLINICAL PERSPECTIVES
Limited data exist on procedural and biophysical predictors of durable pulmonary vein (PV) isolation after the cryoballoon
ablation of atrial ﬁbrillation. While optimal PV occlusion using the cryoballoon remains an important determinant of PV
isolation, its quantiﬁcation may be difﬁcult and subjective. In this study, we examine several procedural and biophysical
variables associated with late PV reconnection and durable PV isolation after cryoablation using the currently available
second-generation cryoballoon. Brieﬂy, data from 435 PVs in 112 consecutive patients who underwent a repeat procedure
14 3 months after an index cryoballoon ablation of atrial ﬁbrillation were examined. The time to PV isolation measured in
real time (time to effect) was found to be markedly shorter, the balloon temperature at time to effect signiﬁcantly warmer,
interval and total thaw times notably longer, and the freeze area under the curve signiﬁcantly colder for durable PV isolation
as compared for late PV reconnection. Yet, a longer duration and greater number of CBAs were not predictive of improved
outcomes. Based on receiver operating characteristic curve analyses, a time to effect ofr60 seconds and an interval thaw
time at 01C ofZ10 seconds provided the greatest area-under-the-curve values for durability of PV isolation. Furthermore,
in a multivariate logistic regression analysis, only these two variables emerged as signiﬁcant predictors of permanent PV
isolation. Consequently, presence of both of these criteria in a multivariate model was shown to predict o1% and their
mere absence 75% likelihood of late PV reconnection during long-term follow-up.
